| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.38▲ | 0.38▲ | 0.38▼ | 0.41▼ | 0.47▼ |
| MA10 | 0.39▼ | 0.39▼ | 0.39▼ | 0.45▼ | 0.51▼ |
| MA20 | 0.39▼ | 0.40▼ | 0.40▼ | 0.49▼ | 0.65▼ |
| MA50 | 0.40▼ | 0.43▼ | 0.45▼ | 0.49▼ | 1.52▼ |
| MA100 | 0.41▼ | 0.47▼ | 0.49▼ | 0.74▼ | 2.12▼ |
| MA200 | 0.46▼ | 0.49▼ | 0.50▼ | 1.43▼ | 10.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | 0.000▲ | 0.000▲ | -0.014▼ | 0.041▲ |
| RSI | 40.364▼ | 38.858▼ | 30.902▼ | 35.044▼ | 32.942▼ |
| STOCH | 4.908▼ | 23.901 | 44.195 | 10.076▼ | 32.455 |
| WILL %R | -78.317▼ | -61.913 | -61.913 | -87.535▼ | -89.204▼ |
| CCI | -60.367 | -45.634 | -86.771 | -132.024▼ | -158.079▼ |
|
Thursday, April 16, 2026 06:10 AM
Class Opioid with Oral Overdose-Protection ~ SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...
|
|
Monday, April 13, 2026 03:07 AM
Detailed price information for Ensysce Biosciences Inc (ENSC-Q) from The Globe and Mail including charting and trades.
|
|
Monday, March 30, 2026 04:51 AM
Detailed price information for Ensysce Biosciences Inc (ENSC-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/04/26 | 0.3868 | 0.3868 | 0.3763 | 0.383 | 126,458 |
| 27/04/26 | 0.3966 | 0.4099 | 0.3521 | 0.3826 | 574,792 |
| 24/04/26 | 0.44 | 0.44 | 0.4059 | 0.4142 | 261,172 |
| 23/04/26 | 0.4352 | 0.4352 | 0.4032 | 0.424 | 261,047 |
| 22/04/26 | 0.4479 | 0.4644 | 0.4228 | 0.4332 | 228,035 |
| 21/04/26 | 0.4901 | 0.4901 | 0.4438 | 0.4518 | 287,302 |
| 20/04/26 | 0.5075 | 0.5101 | 0.4745 | 0.4842 | 206,997 |
| 17/04/26 | 0.511 | 0.539 | 0.494 | 0.50 | 273,503 |
| 16/04/26 | 0.5447 | 0.5447 | 0.4801 | 0.51 | 206,652 |
| 15/04/26 | 0.5175 | 0.539 | 0.5001 | 0.5351 | 98,292 |
|
|
||||
|
|
||||
|
|